Tag Archives: EVR

Top 10 Casino Stocks To Buy For 2018

More than two years after a government crackdown on corruption sent Macau gaming stocks tumbling, The Chinese government has unveiled yet another new regulation on the Macau gaming industry that has hit gaming stocks hard. The latest new law cut the daily ATM withdrawal limit in Macau from 10,000 patacas to 5,000 patacas, or roughly $626.

Unfortunately, transparency and predictability has never been one of the Chinese government’s strong points. Wynn Resorts, Limited (NASDAQ: WYNN) CEO Steve Wynn said the government’s behavior was “preposterous” when it kept operators in the dark about how many table games they would be allotted just weeks prior to opening billion-dollar new resorts. For the record, none of the major operators that have opened resorts in the past two years have received the table allotment they requested.

Although the U.S. gaming market likely doesn’t have the kind of long-term growth potential that Macau does, U.S. casinos are doing just fine these days. In the current fiscal year, Las Vegas Strip revenue is trending about 6% ahead of last year, and other regions of the country are doing even better. For better or worse, U.S. stock investors likely won’t have to worry about new regulations in the next four years under President-elect Trump.

Top 10 Casino Stocks To Buy For 2018: NXP Semiconductors N.V.(NXPI)

Advisors’ Opinion:

  • [By Sreekanth Anasa]

    A recent Reuter’s report suggests that the San Diego, California basedchipmaker is all set to win a conditional Japanese antitrust go-ahead for its multi-billion dollar NXP Semiconductor (NASDAQ:NXPI) deal. Earlier, Bloomberg reported that Qualcomm may win European Union approval for its NXPacquisition by the year-end with slight modifications to the concessions. The smartphone chip giant reportedly seems to have struck a deal with the European regulatory body by agreeing to drop certainstandard essential and system-level patents belonging to NXP in the proposed takeover. EU anti-trust body has now set the new deadline fordeciding on Qualcommsacquisition of NXP asMarch 5, 2018. If Bloomberg reports turn out to be true, this could be shot in the arm for Qualcomm which at the moment is trying to fend off the takeoverfrom Broadcom. If EU approval goes through then other remainingregulatory bodies will soon fall in line.

  • [By Anders Bylund]

    NXP Semiconductors (NASDAQ:NXPI) is closing out 2016 with a 16% return for the full year. Here’s what to expect out of the Netherlands-based embedded chip maker in 2017.

  • [By Sreekanth Anasa]

    This has the potential to offset the sluggishness in demand of smartphone chips around the world. Also, certain performance benchmarks of Qualcomm’s latest flagship processor 835 are making positive waves. A lot is riding on Qualcomm’s $47B acquisition of NXP Semiconductor (NASDAQ:NXPI), which it plans to complete by the end of the year. This acquisition would open up the high potential IoT segment as well for the smartphone chipmaker. All of these positives have been overshadowed by Qualcomm Inc’s legal troubles, which could hit its licensing business hard. Qualcomm depends heavily on its licensing business to generate bulk of its pre-tax profits. In the most recent fiscal year, Qualcomm’s QTL segment accounted for 78% of its pre-tax profits. The verdicts in the legal issues faced by Qualcomm will not be out anytime soon. These tend to be long drawn courtroom battles, and have cast a spell of uncertainty over Qualcomm’s licensing business.

  • [By Sreekanth Anasa]

    The San Diego-based component maker is taking the lead to capture the booming IoT opportunity. A latest BusinessInsider researchsuggests that there will be an investment of “$6 trillion in IoT between 2015 and 2020, which will yield $12.6 trillion ROI over the next decade.” The BI research also “expects that more than 24 billion IoT devices will be installed globally in 2020, and the vast majority of these will fall into the small, low-power category.” Qualcomm has stepped up its efforts to capture the massive opportunity in front of it by its latest moves. The world’s largest smartphone chipmaker has announced its IoT chips “with support for Android Things OS, integration with Amazon Web Services, and two systems-on-chips that aggregate a bevy of standards.” A number of Qualcomm’s offerings are being showcased atMobile World Congress in Barcelona later this week. It is also known that Qualcomm is “first to add support for Google’s Android Things OS on its 4G LTE processors”. As a ZDNet post puts it Qualcomm wants to “Be the Swiss Army processor for IoT deployments.” All these advancements are from Qualcomm alone, and once the NXP Semiconductor (NASDAQ:NXPI) acquisition is over, the chipmaker’s IoTportfoliowill become very diverse and large, to tap the Multi-billion dollar opportunity.

  • [By WWW.THESTREET.COM]

    Intel Is Getting Serious About Self-Driving Cars, But It’s Not All Smooth Roads Ahead
    The chip giant’s (INTC) deals with Delphi and BMW are proof it’s taking the autonomous driving market seriously. But Nvidia (NVDA) and Qualcomm (QCOM) /NXP (NXPI) present stiff competition. Full story

  • [By Anders Bylund]

    Just five months ago, fellow Fool Leo Sun compared the investing theses for Intel (NASDAQ:INTC) and NXP Semiconductors (NASDAQ:NXPI). He found NXP to be the better pick, thanks to massive growth opportunities and a low PEG ratio.

Top 10 Casino Stocks To Buy For 2018: Archer-Daniels-Midland Company(ADM)

Advisors’ Opinion:

  • [By WWW.MONEYSHOW.COM]

    Aflac (AFL) — yielding 2.5%
    Archer-Daniels Midland (ADM) — yielding 2.7%
    Chevron (CVX) — yielding 3.8%
    ExxonMobil (XOM) — yielding 3.6%
    Genuine Parts (GPC) — yielding 2.7%
    Johnson & Johnson (JNJ) — yielding 2.8%
    T. Rowe Price (TROW) — yielding 3.2%

Top 10 Casino Stocks To Buy For 2018: Carter's, Inc.(CRI)

Advisors’ Opinion:

  • [By Ben Levisohn]

    After running through their scenarios,Boruchow comes up with five losers from Trump’s tax plans: Carters (CRI), Urban Outfitters (URBN), Under Armour (UA), Fossil Group (FOSL) and Gap (GPS). He explains why:

Top 10 Casino Stocks To Buy For 2018: AXT Inc(AXTI)

Advisors’ Opinion:

  • [By Lisa Levin] Related CRMD Mid-Day Market Update: U.S. Stocks Turn Negative; AveXis Shares Spike Higher 12 Biggest Mid-Day Gainers For Tuesday CorMedix's (CRMD) CEO Khoso Baluch on Q4 2016 Results – Earnings Call Transcript (Seeking Alpha)
    Related BIOA Mid-Day Market Update: U.S. Stocks Turn Negative; AveXis Shares Spike Higher Mid-Morning Market Update: Markets Edge Higher; Tiffany Earnings Top Estimates BioAmber (BIOA) Q4 2016 Results – Earnings Call Transcript (Seeking Alpha)
    CorMedix Inc. (NYSE: CRMD) shares fell 27.5 percent to $1.50 after the company reported Q4 results and issued a business update.
    Bioamber Inc (NYSE: BIOA) shares tumbled 23.6 percent to $2.40. BioAmber reported FY16 adjusted loss of $1.07 per share on revenue of $8.3 million.
    The Medicines Company (NASDAQ: MDCO) shares dipped 20.9 percent to $41.62.
    Innocoll Holdings PLC (NASDAQ: INNL) shares fell 20.3 percent to $1.49. Innocoll posted a narrower-than-expected quarter loss, but revenue missed estimates. Stifel Nicolaus downgraded Innocoll from Buy to Hold.
    Rosetta Genomics Ltd. (USA) (NASDAQ: ROSG) shares declined 20.3 percent to $3.83. On Thursday, Rosetta Genomics disclosed a 1-for-12 reverse stock split.
    Esperion Therapeutics Inc (NASDAQ: ESPR) shares dropped 19.9 percent to $23.76. Esperion Therapeutics shares have jumped 106.19 percent over the past 52 weeks, while the S&P 500 index has gained 16.70 percent in the same period.
    AmTrust Financial Services Inc (NASDAQ: AFSI) tumbled 18.3 percent to $17.65. AmTrust Financial disclosed that it will delay its annual report filing for the fiscal year ended December 31, 2016.
    Qualstar Corporation (NASDAQ: QBAK) slipped 17.7 percent to $6.85. Qualstar reported a Q4 loss of $0.20 per share on revenue of $2.2 milli

Top 10 Casino Stocks To Buy For 2018: Buenaventura Mining Company Inc.(BVN)

Advisors’ Opinion:

  • [By WWW.GURUFOCUS.COM]

    For the details of Somerset Capital Management LLP’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=Somerset+Capital+Management+LLP

    These are the top 5 holdings of Somerset Capital Management LLPFomento Economico Mexicano SAB de CV (FMX) – 1,268,818 shares, 36.15% of the total portfolio. Shares reduced by 9.36%Yandex NV (YNDX) – 3,352,412 shares, 25.48% of the total portfolio. Shares reduced by 3.61%ICICI Bank Ltd (IBN) – 5,074,899 shares, 13.19% of the total portfolio. Shares reduced by 11.08%Infosys Ltd (INFY) – 1,596,414 shares, 6.95% of the total portfolio. Shares reduced by 15.58%KT Corp (KT) – 1,330,431 shares, 6.41% of the

  • [By Alex McGuire]

    You see, Money Morning Resource Specialist Peter Krauth expects gold prices to gain 15.4% from their current $1,213 level to $1,400 an ounce this year. This rise will lead to an even bigger rally for gold stocks. Since the beginning of 2017, gold prices are up 5.1%. But the gains in gold stocks like Agnico Eagle Mines Ltd. (NYSE:AEM) and Compania de Minas Buenaventura SAA (NYSE ADR: BVN) have doubled and quadrupled the year-to-date gold price return.

Top 10 Casino Stocks To Buy For 2018: Iteris, Inc.(ITI)

Advisors’ Opinion:

  • [By Lisa Levin]

    Gainers

    Pyxis Tankers Inc. (NYSE: PXS) rose 47.48 percent to $$5.56, after the company announced it has entered into a definitive securities purchase agreement with a group of investors, which will result in gross proceeds of $4.8 million.
    Sigma Designs Inc (NASDAQ: SIGM) rose 22.77 percent to $6.88. Silicon Laboratories (NASDAQ: SLAB) announced plans to buy Sigma Designs for $7.05 per share in cash.
    Steadymed Ltd (NASDAQ: STDY) rose 19.35 percent to $3.70, after the company reported that no clinical trials were required for Trevyent and that the FDA had agreed to the pathway for the drug candidate's NDA resubmission.
    Iteris, Inc. (NASDAQ: ITI) rose 15.73 percent to $7.06. Earlier in the week, Zacks Investment Research had upgraded the company from "Sell" to "Hold".
    Science Applications International Corp (NYSE: SAIC) rose 13.71 percent to $85.77 as the company reported better-than-expected earnings for its third quarter.
    Technical Communications Corporation (NASDAQ: TCCO) rose 12.41 percent to $6.07, after having risen sharply in pre-marketing trading.
    Radius Health, Inc. (NASDAQ: RDUS) rose 12.41 percent to $30.81 after the company provided an update on data from the Phase 1 005 clinical study of elacestrant in patients with estrogen receptor positive breast cancer during the 2017 San Antonio Breast Cancer Symposium.
    ForeScout Technologies, Inc. (NASDAQ: FSCT) rose 12.32 percent to $25.80 after the company reported its third quarter financial results.
    Prana Biotechnology Limited (NASDAQ: PRAN) rose 11.36 percent to $3.43, as the company announced a research collaboration with Takeda Pharmaceuticals to study the ability of movement disorders compound, PBT434 to slow or prevent neurodegeneration of the gastrointestinal system.
    Catalyst Biosciences, Inc. (NASDAQ: CBIO) rose 10.49 percent to $7.90 as the company announced the appointment of Arwa Shurrab and Jamie Ellen Siegel in its clinical hemophilia

Top 10 Casino Stocks To Buy For 2018: The Kraft Heinz Company(KHC)

Advisors’ Opinion:

  • [By Diane Alter]

    Mondelez International stock is up this week on chatter a takeover offer from Kraft-Heinz Co. (NYSE: KHC) could be coming.

    Shares of Mondelez International Inc. (Nasdaq: MDLZ) surged 6% after hours Wednesday as rumors spread that Pittsburgh-based Kraft-Heinz might be interested in purchasing Chicago-headquartered Mondelez. German business magazine Bilanz first reported about the possible takeover.

  • [By Daniel Miller]

    The Kraft Heinz Company (NASDAQ:KHC) made headlines Friday morning after it announced a proposed $143 billion merger with Unilever in what would potentially be one of the biggest deals in history. Unfortunately, at least for now, the latter has declined, as it doesn’t see strategic or financial merit at this time. But surely Kraft has no plans to give up on this match made in heaven that could place key parts of your fridge under one company umbrella. The combined company would combine Hellmann’s mayo, Heinz ketchup, Kraft Mac & Cheese, Oscar Mayer hot dogs, Philadelphia cream cheese, and among many other products, Ben & Jerry’s ice cream.

  • [By Arie Goren]

    Berkshire’s largest holding, by far, in a public company is Kraft Heinz (NSDQ:KHC). It’s holding value is about $28.5 billion, about 20% of the total holding of all the 48 companies in Berkshire Hathaway’s public companies portfolio. Moreover, Berkshire owns a stake of 26.6% in the company. As such, the performance of KHC’s stock will have a significant influence on Berkshire’s future results.

  • [By Dustin Blitchok]

    Morrison has led Campbell Soup since August 2011 and has worked in the food business for more than 30 years, including at Kraft Heinz Co (NASDAQ: KHC), Nabisco, Nestle SA (ADR) (OTC: NSRGY) and PepsiCo, Inc. (NYSE: PEP).

  • [By Ben Levisohn]

    Susquehanna’s Pablo Zuanic and team note that Keurig’s business in K-cups has been slowing ever since it was bought by JAB, a problem that could be solved in a very convoluted way by a Mondelez International (MDLZ)-Kraft Heinz (KHC) merger. They explain:

  • [By Jon C. Ogg]

    The 325,442,152 shares Berkshire owns of Kraft Heinz Co. (NASDAQ: KHC) are carried onthe balance sheet at a GAAP figure of $15.3 billion and had a year-end market value of $28.4 billion. The cost basis for the shares is $9.8 billion.

Top 10 Casino Stocks To Buy For 2018: PIMCO 25+ Year Zero Coupon US Trs ETF (ZROZ)

Advisors’ Opinion:

  • [By Todd Shriber, ETF Professor]

    Investors with a taste more rate-sensitive bond ETF may want to consider the PIMCO 25 Yr Zro Cupn US Ty Inx Fd ETF (NYSE: ZROZ) and the Vanguard Extended Duration ETF (NYSE: EDV).

Top 10 Casino Stocks To Buy For 2018: BioMarin Pharmaceutical Inc.(BMRN)

Advisors’ Opinion:

  • [By George Budwell, Rich Smith, and Matthew DiLallo]

    With this question in mind, we asked three of our contributors which stocks they recommend to buy and hold for the next 20 years. They suggestedBioMarin Pharmaceutical (NASDAQ:BMRN), Enterprise Products Partners (NYSE:EPD), andLockheed Martin (NYSE:LMT). Below, they discuss why they chose these particular stocks, and why investors with a long-term outlook may want to consider adding them to their portfolios right now.

  • [By Keith Speights]

    You might not have heard too much about Akebia Therapeutics (NASDAQ:AKBA), BioMarin Pharmaceutical (NASDAQ:BMRN), and Idera Pharmaceuticals (NASDAQ:IDRA). These are three biotech stocks that you could be overlooking — but deserve your attention. Here’s why.

  • [By Ben Levisohn]

    Skorney’s namesVertex Pharmaceuticals (VRTX),Sarepta Therapeutics (SRPT), and Curis (CRIS) his top biotech picks for 2017, while Ulz chosesBioMarin Pharmaceutical (BMRN) andParatek Pharmaceuticals (PRTK).

Top 10 Casino Stocks To Buy For 2018: Evercore Partners Inc(EVR)

Advisors’ Opinion:

  • [By Diane Alter]

    The New York Times first reported that Frontier Airlines is prepping for an initial public offering. The Denver, Colo.-based low-cost carrier has hired Deutsch Bank (NYSE: DB), JPMorgan Chase & Co. (NYSE: JPM), and Evercore Partners Inc. (NYSE: EVR) to handle the IPO. The airline started the process late last year when it approached a number of bankers.

Top 10 Casino Stocks To Invest In Right Now

What happened

Shares ofPenn National Gaming, Inc. (NASDAQ:PENN), casino operator and equipment maker largely focused on slot machines, climbed 28% throughout March, according to data fromS&P Global Market Intelligence, after the company announced that it raised financial guidance for the first quarter of 2017 ending March 31.

So what

About a week before the quarter ended, Penn management released updated estimates for the quarter, including revenue of $771 million on the upper end of the range, which was up from the previous guidance of $761 million, and would be about 2% higher than Q1 2016. The company also raised its Adjusted EBITDA guidance from$209.3 million to an expected range of$222 million and $223 million.Penn’s official Q1 earnings are expected to be released on April 27, and during that earnings release, the company will give full-year 2017 guidance.

Image source: Getty Images.

Top 10 Casino Stocks To Invest In Right Now: Express-1 Expedited Solutions Inc.(XPO)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    In the Lightning Round, Cramer was bullish on GlaxoSmithKline (GSK) , Chubb (CB) , XPO Logistics (XPO) , FedEx (FDX) and Nordson (NDSN) .

    Cramer was bearish on Prudential (PRU) , Advanced Semiconductor Engineering (ASX) and ZTO Express (ZTO) .

  • [By WWW.THESTREET.COM]

    With a trailing 12-month price-to-earnings ratio of 28.79, FedEx’s valuation is in line with UPS (27.52) and far cheaper than XPO Logistics (XPO) (90.25).

Top 10 Casino Stocks To Invest In Right Now: Graco Inc.(GGG)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Thursday, industrials shares fell by 0.83 percent. Meanwhile, top losers in the sector included Graco Inc. (NYSE: GGG), down 9 percent, and Southwest Airlines Co (NYSE: LUV), down 11 percent.

  • [By Joel Elconin]

    At this time, the only relevant news to the Gold market and Gold stocks was the halt of Graco Inc. (NYSE: GGG), which was down $0.80 at $84.64 and just reopened at $82.20.

Top 10 Casino Stocks To Invest In Right Now: Evercore Partners Inc(EVR)

Advisors’ Opinion:

  • [By Diane Alter]

    The New York Times first reported that Frontier Airlines is prepping for an initial public offering. The Denver, Colo.-based low-cost carrier has hired Deutsch Bank (NYSE: DB), JPMorgan Chase & Co. (NYSE: JPM), and Evercore Partners Inc. (NYSE: EVR) to handle the IPO. The airline started the process late last year when it approached a number of bankers.

Top 10 Casino Stocks To Invest In Right Now: Foresight Energy LP(FELP)

Advisors’ Opinion:

  • [By Laurie Kulikowski]

    FORESIGHT ENERGY LP has experienced a steep decline in earnings per share in the most recent quarter in comparison to its performance from the same quarter a year ago. This company has reported somewhat volatile earnings recently. We feel it is likely to report a decline in earnings in the coming year. During the past fiscal year, FORESIGHT ENERGY LP increased its bottom line by earning $0.78 versus $0.08 in the prior year. For the next year, the market is expecting a contraction of 67.9% in earnings ($0.25 versus $0.78).

     

  • [By Laurie Kulikowski]

    Despite any intermediate fluctuations, we have only bad news to report on this stock’s performance over the last year: it has tumbled by 83.17%, worse than the S&P 500’s performance. Consistent with the plunge in the stock price, the company’s earnings per share are down 82.85% compared to the year-earlier quarter. Naturally, the overall market trend is bound to be a significant factor. However, in one sense, the stock’s sharp decline last year is a positive for future investors, making it cheaper (in proportion to its earnings over the past year) than most other stocks in its industry. But due to other concerns, we feel the stock is still not a good buy right now.

     

  • [By Laurie Kulikowski]

    After the recent distribution cut, Foresight’s distribution coverage is over 6.0x with much of the future cash flow dedicated to reducing leverage. It has over 80% of its coal sales priced for next year and its costs should improve as the low cost Hillsboro mine comes back into production early next year. It is also benefitting from cost synergies with the Murray operations. We believe Foresight’s new distribution level is sustainable. With its 15.5% yield, we feel FELP could be attractive to income seeking investors. 

  • [By Laurie Kulikowski]

    The change in net income from the same quarter one year ago has exceeded that of the Oil, Gas & Consumable Fuels industry average, but is less than that of the S&P 500. The net income has significantly decreased by 82.3% when compared to the same quarter one year ago, falling from $45.72 million to $8.07 million.

     

  • [By Laurie Kulikowski]

    We rate FORESIGHT ENERGY LP as a Sell with a ratings score of E+. This is based on a variety of negative investment measures, which should drive this stock to significantly underperform the majority of stocks that we rate. The company’s weaknesses can be seen in multiple areas, such as its generally high debt management risk, poor profit margins, generally disappointing historical performance in the stock itself, deteriorating net income and feeble growth in its earnings per share. 

  • [By Laurie Kulikowski]

    The debt-to-equity ratio is very high at 18.59 and currently higher than the industry average, implying increased risk associated with the management of debt levels within the company. To add to this, FELP has a quick ratio of 0.56, this demonstrates the lack of ability of the company to cover short-term liquidity needs.

     

Top 10 Casino Stocks To Invest In Right Now: iAnthus Capital Holdings, Inc. (ITHUF)

Advisors’ Opinion:

  • [By Javier Hasse]

    Earlier this month, cannabis-focused financing and advisory firm iAnthus Capital Holdings Inc (CNSX: IAN) (OTC: ITHUF) announced it acquired Westchester-based Valley Agriceuticals, LLC, gaining access to New York’s nascent cannabis market.

  • [By Javier Hasse]

    The Green Solution received a $7.5 million loan facility from iAnthus Capital Holdings Inc (OTC: ITHUF).

    “This was also to accelerate expansion within Colorado and going into other states nation-wide.”

    Valens Groworks Corp (CNSX: VGW), a Canadian post-inspection applicant for cannabis cultivation and processing, raised C$500,000 ($381,431) under a convertible note to meet acquisition and expansion obligations.

  • [By Javier Hasse]

    Over the past few weeks, Benzinga has been sharing interviews with the top venture capital and investment firms operating in the cannabis industry. Among those focused on ancillary businesses that do not touch the plant, we profiled Snoop Dogg’s Casa Verde and Arcview Group partner, CanopyBoulder. Among those willing to get involved in plant-touching ventures, we presented MJIC, which claims it intends to become the “Amazon.com, Inc. (NASDAQ: AMZN) of weed,” and iAnthus Capital Holdings Inc (CNSX: IAN) (OTC: ITHUF), which raises capital for U.S.-based marijuana companies in Canadian capital markets.

Top 10 Casino Stocks To Invest In Right Now: JinkoSolar Holding Company Limited(JKS)

Advisors’ Opinion:

  • [By Elizabeth Balboa]

    First Solar, Inc (NASDAQ: FSLR) was trading down 3.7 percent Monday, while JA Solar Holdings Co., Ltd. (ADR) (NASDAQ: JASO) was down 0.8 percent, SunPower Corporation (NASDAQ: SPWR) 4.4 percent, Canadian Solar Inc. (NASDAQ: CSIQ) 5.2 percent and JinkoSolar Holding Co., Ltd. (NYSE: JKS) 4.4 percent.

  • [By Paul Ausick]

    It is not often that a secondary stock offering sends a companys shares higher, but we are seeing that very phenomenon Friday morning. Chinese solar PV maker JinkoSolar Holding Co. Ltd. (NYSE: JKS) and stock image company Shutterstock Inc. (NASDAQ: SSTK) both priced secondary offerings this morning and shares in both companies have risen sharply.

  • [By Lisa Levin]

    In trading on Monday, energy shares fell by 0.59 percent. Meanwhile, top losers in the sector included JinkoSolar Holding Co., Ltd. (NYSE: JKS), down 8 percent, and Teekay Offshore Partners L.P. (NYSE: TOO) down 7 percent.

  • [By Lisa Levin]

    JinkoSolar Holding Co (NYSE: JKS) dropped 9.88% to $16.87 after the company announced the offering of 3,500,000 American Depositary Shares.

    Fuwei Films (Holdings) Co (NASDAQ: FFHL) dropped 9.66% to $1.30. Fuwei Films’ trailing-twelve-month ROE is -10.85%.

  • [By Paul Ausick]

    But the real news is the near vertical trajectory in share prices for the two stocks. This could be another manifestation of the markets hunger for some momentum plays, as we noted earlier this morning the bump to share prices for both JinkoSolar Holding Co. Ltd. (NYSE: JKS) and Shutterstock Inc. (NASDAQ: SSTK), both of which held secondary share sales this morning.

Top 10 Casino Stocks To Invest In Right Now: Ligand Pharmaceuticals Incorporated(LGND)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Monday, healthcare shares were relative laggards, down on the day by about 0.51 percent. Meanwhile, top losers in the sector included Ligand Pharmaceuticals Inc. (NASDAQ: LGND), down 8 percent, and ImmunoGen, Inc. (NASDAQ: IMGN) down 7 percent.

  • [By Lisa Levin]

    Ligand Pharmaceuticals Inc. (NASDAQ: LGND) shares dropped 6 percent to $132.26. Deutsche Bank downgraded Ligand Pharmaceuticals from Hold to Sell.

  • [By Keith Speights]

    Research and development is the lifeblood of biotech companies. The potential for new drugs also serves as a primary factor driving biotech stocks higher and higher. That’s been the case for Celgene (NASDAQ:CELG), Ionis Pharmaceuticals (NASDAQ:IONS), and Ligand Pharmaceuticals (NASDAQ:LGND).

Top 10 Casino Stocks To Invest In Right Now: J.B. Hunt Transport Services Inc.(JBHT)

Advisors’ Opinion:

  • [By Lisa Levin]

    Here is the list of stocks going ex-dividend on August 3, 2016.

    J B Hunt Transport Services Inc (NASDAQ: JBHT) – $0.2200 dividend, 1.0791 percent yield
    Johnson Controls Inc (NYSE: JCI) – $0.2900 dividend, 2.6250 percent yield
    FirstEnergy Corp. (NYSE: FE) – $0.3600 dividend, 3.9680 percent yield
    Sunoco LP (NYSE: SUN) – $0.8255 dividend, 10.7347 percent yield
    Wells Fargo & Co (NYSE: WFC) – $0.3800 dividend, 3.1588 percent yield
    BP plc (ADR) (NYSE: BP) – $0.6000 dividend, 6.8768 percent yield
    American Airlines Group Inc (NASDAQ: AAL) – $0.1000 dividend, 1.1442 percent yield
    Heidrick & Struggles International, Inc. (NASDAQ: HSII) – $0.1300 dividend, 2.9834 percent yield
    Alcoa Inc (NYSE: AA) – $0.0300 dividend, 1.1321 percent yield
    Sensient Technologies Corporation (NYSE: SXT) – $0.2700 dividend, 1.5341 percent yield

    Posted-In: Ex-DividendNews Dividends Markets Trading Ideas

Top 10 Casino Stocks To Invest In Right Now: eLong, Inc.(LONG)

Advisors’ Opinion:

  • [By Monica Gerson]

    eLong, Inc. (ADR) (NASDAQ: LONG) is projected to post a quarterly loss at $0.60 per share on revenue of $38.31 million.

    Qunar Cayman Islands Ltd (NASDAQ: QUNR) is expected to post a quarterly loss at $8.89 per share on revenue of $1.11 billion.

Top 10 Casino Stocks To Invest In Right Now: NewStar Financial, Inc.(NEWS)

Advisors’ Opinion:

  • [By Lisa Levin] Related AHT 25 Biggest Mid-Day Gainers For Friday Mid-Day Market Update: Hortonworks Drops Following Weak Results; Freshpet Shares Spike Higher Ashford Hospitality Trust's (AHT) CEO Montgomery Bennet on Q2 2016 Results – Earnings Call Transcript (Seeking Alpha)
    Related NEWS Mid-Morning Market Update: Markets Open Higher; Micron To Lower Jobs Mid-Morning Market Update: Markets Open Lower; Broadcom Profit Beats Expectations NewStar Financial's (NEWS) CEO Tim Conway on Q2 2016 Results – Earnings Call Transcript (Seeking Alpha)

     

hot penny stocks

European stocks, which have lagged their U.S. counterparts dramatically since the bull market began in 2009, are closing the gap. In the first five months of 2017, the MSCI Europe index returned 16.6%nearly double the return of Standard & Poors 500-stock index.

See Also: Great Foreign Stocks That Pay Dividends

Whats behind Europes resurgence? For one thing, European stocks are relatively cheap, trading, on average, at 15 times estimated year-ahead earnings, compared with 18 for the S&P 500. Moreover, European companies are likely to deliver better profit gains than U.S. companies this year. Wall Street sees European companies boosting earnings by 22% in 2017, twice the rate of U.S. firms.

The improved outlook stems from growing optimism about the global economy. The International Monetary Fund expects a 3.5% boost in global growth this year and a 3.6% uptick in 2018. Analysts say that should disproportionately benefit European firms, which generate nearly half of their sales outside of the Continent.

hot penny stocks: Vitality Biopharma (VBIO)

Advisors’ Opinion:

  • [By Jim Robertson]

    Yesterday, small cap cannabinoid prodrug pharmaceutical stock Vitality Biopharma, Inc. (OTCQB: VBIO) announcedthe filing of an international patent application that describes compounds discovered to be effective for neural repair treatments. The underlying patent rights were assigned to Vitality Biopharma in March 2016 and are based on work performed by the Myelin Repair Foundation (MRF) -a non-profit disease research organization that was dedicated to developing regenerative therapies for multiple sclerosis.

  • [By James E. Brumley]

    Investors who were looking to learn a little more about up-and-coming drug development company Vitality Biopharma Inc (OTCMKTS:VBIO) may want to mark December 8th on their calendar…. if they’re going to be in the Los Angeles area that day anyway. The company will be making a presentation that day, at the annual LD Micro Main Event. Interested and approved investors can attend the VBIO presentation by registering beforehand with LD Micro.

    Vitality Biopharma has found a way to make cannabinoid-based pharmaceuticals without the usual downside of cannabinoids. Namely, Vitality Biopharma’s version of cannabinoids are non-psychotropic, meaning larger, more effective dosing is possible without the ‘high’. It’s this little detail that takes cannabinoid medicine — already the most compelling frontier in the world of pharma — to the next level. There’s a reason some people think the cannabinoid market could be worth $20 billion by 2020.

    The idea was significantly advanced in early November. In eight of the nine states voters were asked about legalization of marijuana (for one reason or another), voters said yes….. four for recreational use, and four for medical use. In eight of those nine states, the measures passed. Marijuana is legal in more than half the United States now, and we’re en route to a decided majority in the foreseeable future.

    VBIO didn’t necessarily need a sweeping victory at the ballot box, but each time marijuana wins, it seems to advance the discussion of the power of cannabinoids as medicine.

    Investors will be able to learn more about Vitality Biopharma’s work in that arena on Thursday of this week. On that day — 8 AM PST / 11 AM EST — at the Luxe Sunset Boulevard Hotel in Los Angeles, CA. Robert Brooke, CEO of Vitality Biopharma, will be making a presentation as well as meeting with current and prospective investors.

    LD Micro was founded in 2006 with the sole purpose of being an independent resource in t

  • [By James E. Brumley]

    In mid-September, Vitality Biopharma Inc (OTCMKTS:VBIO) announced it was going to take aim at the development of an alternative to opioids as a means of treating pain. At the time, there was little doubt that the company’s cannabinoid science was capable of doing so. What wasn’t clear to VBIO shareholders was exactly how that might happen…. meaning what sort of drug might Vitality Biopharma come up with.

    We got the first of what will likely be several answers to the question today. Per today’s press release, Vitality Biopharma intends to come up with a treatment for narcotic bowel syndrome, which is a severe form of (ironically enough) opiate-induced abdominal pain.

    As a refresher, Vitality Biopharma was the name we introduced to you back on August 8th, pointing out it had developed a whole new way of making cannabinoid-based medicines. Their versions offer all the upsides of cannabinoids, but without the psychotropic (“getting high’) effects, and without some of the common downsides associated with these pharmaceuticals… like mouth and skin lesions.

    There are even bigger advantages to Vitality Biopharma’s science, however. Namely, since these drugs are prodrugs and aren’t activated until in the body, they allow for targeted delivery to the GI tract (yet can also selectively target other body parts, even as far away from the GI tract as the brain). Perhaps more than anything though, these drugs are orally-administered by virtue of being highly soluble, making them easy to use.

    It’s this nuance that makes Vitality Biopharma’s recently-announced intention so interesting, and compelling.

    Studies have found that up to 81% of patients treated with opiates have functional bowel disorders, with more than half — 58% to be exact — of opiate users reporting chronic abdominal pain stemming from the use of their prescribed painkillers. Considering 200 million opioid prescriptions are filled every year in the United States alo

  • [By Jim Robertson]

    That’s why its worth pointing out that just yesterday, small cap cannabinoid prodrug pharmaceutical stock Vitality Biopharma, Inc. (OTCQB: VBIO) announced the appointment of Tracy Rockney, J.D. to the position of Senior Regulatory Advisor. In addition to being the Co-Founder & Chief Operating Officer of OneSource Regulatory, a regulatory consulting firm, Rockney was previously:

  • [By James E. Brumley]

    Are you an investor interested in learning more about Vitality Biopharma Inc (OTCMKTS:VBIO)? Or, are you looking to take your first look at VBIO? A SeeThruEquity research report posted in August not only has you covered, it underscores all of its hidden bullishness. The report also explains a very impressive target price for Vitality Biopharma shares. In short, the research outfit now believes the stock will see $2.00 per share sooner than later, based on its pipeline and potential market penetration. That’s 38% higher than its current value.

  • [By Matthew Briar]

    Back in September, Vitality Biopharma Inc (OTCMKTS:VBIO) CEO Robert Brooke officially announced his company would be entering the painkiller market, specifically taking aim at the development of an alternative to opioids. His specific words? “Opiates are one of the key classes of drugs we’re seeking to replace, or to make far less necessary, as our proprietary cannabosides could provide a potent alternative form of pain relief and help avoid, or greatly reduce, the use of opiates for the treatment of many conditions…”

hot penny stocks: Utilities Select Sector SPDR ETF (XLU)

Advisors’ Opinion:

  • [By Craig Jones]

    On CNBC's Options Action, Dan Nathan suggested a bearish options trading idea in Utilities SPDR (ETF) (NYSE: XLU).

    The stock caught his attention, because he noticed a big put options volume last week in the name. He thinks traders should not be in the stock ahead of a possible rate hike.

  • [By WWW.MONEYSHOW.COM]

    With a little more than $6 billion in assets and average daily trading volumes in excess of 12 million shares per day, SPDR Utilities (XLU) is the top choice to hold during Utilities seasonally favorable period. It has a gross expense ratio of just 0.14% and comes with the added kicker of a 3.37% dividend yield.

  • [By Craig Jones]

    Speaking on Bloomberg Markets, Kevin Kelly of Recon Capital Partners suggested that investors with a long position in Utilities SPDR (ETF) (NYSE: XLU) should consider an options strategy that offers protection ahead of the FOMC meeting.

  • [By WWW.THESTREET.COM]

    The Dow utility average ended last week at a stabilizing 639.95 after trading as low as 616.19 on Nov. 14. Keep in mind that a “death cross” was confirmed on election day, when the 50-day simple moving average fell below the 200-day simple moving average, indicating that lower prices are likely ahead. The 200-day is now at 666.30. The utility average has returned to my range of key levels of 635.23 and 670.81, which remain magnets for the remainder of 2016. This week’s value level is above the Nov. 14 low at 620.87. Investors seeking the safety of dividends can trade the Utilities Select Sector SPDR Fund (XLU) , which is a basket of 28 utility stocks.

hot penny stocks: Zillow Group, Inc.(ZG)

Advisors’ Opinion:

  • [By Steve Symington]

    Shares of Zillow Group Inc. (NASDAQ:Z)(NASDAQ:ZG)climbed 13.8% in the month of April,according to data provided byS&P Global Market Intelligence, ahead of the online real estate specialist’s impending first-quarter 2017 report.

  • [By Steve Symington]

    The stock market was mostly flat today ahead of a key House vote on the passage of the Republicans’ healthcare bill, which was delayed until Friday after GOP lawmakers failed to gather the necessary support. TheDow Jones Industrial Averagelost just 5 points, or 0.02%, while other broader market indexes saw similar small declines. But several individual stocks saw much more severe drops, including Zillow Group (NASDAQ:Z) (NASDAQ:ZG), Proofpoint (NASDAQ:PFPT), and Accenture (NYSE:ACN). Read on to see what drove these unusual moves.

hot penny stocks: Evercore Partners Inc(EVR)

Advisors’ Opinion:

  • [By Diane Alter]

    The New York Times first reported that Frontier Airlines is prepping for an initial public offering. The Denver, Colo.-based low-cost carrier has hired Deutsch Bank (NYSE: DB), JPMorgan Chase & Co. (NYSE: JPM), and Evercore Partners Inc. (NYSE: EVR) to handle the IPO. The airline started the process late last year when it approached a number of bankers.